Garodia Chemical Q1 Results: Loss widens to ₹10.39 lakh in Q1
Garodia Chemicals posted a Q1FY27 net loss of ₹10.39 lakh, up from ₹5.81 lakh YoY, with no operational revenue. Expenses rose 78.8% due to higher other costs. The board appointed Sarita Subhash Salunkhe as an additional director and scheduled the AGM for September 30, 2026.
*this image is generated using AI for illustrative purposes only.
Garodia Chemicals Limited reported a net loss of ₹10.39 lakh for the quarter ended June 30, 2026, widening from a loss of ₹5.81 lakh in the corresponding period of FY25. The company logged zero revenue from operations for the third consecutive quarter disclosed in the filing, with total expenses increasing by 78.8% year-on-year.
The Board of Directors approved the unaudited financial results and the appointment of Mrs. Sarita Subhash Salunkhe as an additional non-executive non-independent director on August 14, 2026. Her appointment is subject to shareholder approval at the upcoming Annual General Meeting.
Financial Performance
The company’s standalone results reflect a continued absence of operational revenue. Total expenses for the quarter stood at ₹10.39 lakh, compared to ₹5.81 lakh in Q1FY26. This increase was driven largely by a rise in other expenses, which jumped from ₹5.06 lakh to ₹9.64 lakh. Employee benefits expense remained flat at ₹0.75 lakh.
| Metric | Q1FY27 (₹ lakh) | Q1FY26 (₹ lakh) | Change |
|---|---|---|---|
| Revenue from operations | - | - | - |
| Other income | - | - | - |
| Total expenses | 10.39 | 5.81 | +78.8% |
| Net Loss | (10.39) | (5.81) | +78.8% |
For the full fiscal year ended March 31, 2026, Garodia Chemicals reported a net profit of ₹391.67 lakh, primarily driven by other income of ₹405.88 lakh. Total expenses for FY26 were ₹14.21 lakh.
What the Numbers Show
The financial data reveals a stark divergence between the company’s quarterly operational status and its annual profitability. While Q1FY27 shows a pure operating loss with zero revenue, the full-year FY26 profit was entirely dependent on non-operational other income, which constituted approximately 99% of total revenue for the year. This indicates that core business operations did not contribute to the bottom line in FY26, raising questions about the sustainability of earnings without such exceptional items.
Corporate Governance Updates
In addition to the financial results, the board approved the appointment of Mrs. Sarita Subhash Salunkhe (DIN: 11684409) as an additional director effective August 14, 2026. She is liable to retire by rotation and will serve until shareholder approval is secured. Mrs. Salunkhe is the mother of Mr. Ravi Salunkhe, the Managing Director of the company.
The company has scheduled its Annual General Meeting for September 30, 2026, to be held via video conference. The trading window for designated persons remained closed from July 1, 2026, until 48 hours after the declaration of these results, in compliance with SEBI’s insider trading regulations.
Laxmikant Kabra and Co LLP served as the independent auditor for the review, issuing an unmodified opinion on the standalone unaudited financial results prepared in accordance with Ind AS 34.
What strategic steps is Garodia Chemicals taking to revive core operational revenue, given three consecutive quarters of zero income?
How will the appointment of Mrs. Sarita Subhash Salunkhe influence the company's governance structure and future decision-making processes?
Given the FY26 profit was driven by non-operational other income, what are the prospects for sustaining profitability without such exceptional items in FY27?
16
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
